ArticleFrontiers in surgery2025
Peri-lead edema in deep brain stimulation: common complication or rare challenge?
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Speech Biomarkers for Quantifying Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease.Annals of neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Peri-lead edema (PLE) is a commonly observed but often asymptomatic complication of deep brain stimulation (DBS). While usually transient and benign, severe cases of PLE can result in neurological symptoms, impacting patient outcomes. This case series explores the clinical course, management, and outcomes of symptomatic PLE in a series of five patients undergoing DBS. Objective: To analyze the presentation and management strategies for symptomatic peri-lead edema identified in patients undergoing DBS for movement disorders. Methods: A retrospective review of 191 patients who underwent DBS at the University Hospital in Olomouc, Czech Republic, between 2008 and 2024 was conducted. Postoperative imaging and clinical follow-ups were used to identify and evaluate cases of symptomatic PLE. Patients who developed symptomatic PLE were treated with corticosteroids and monitored through imaging and neurological assessments. Results: Among the 191 patients, we identified 5 (2.6%) who developed symptomatic PLE characterized by cognitive decline, motor disturbances, and, in some cases, pseudocyst formation. Symptoms typically presented several weeks to months postoperatively. Management with corticosteroid therapy resulted in clinical improvement and resolution of edema in all cases. Following the resolution of PLE, DBS therapy was successfully re-initiated, achieving favorable therapeutic outcomes. Conclusions: Symptomatic PLE is a rare but clinically significant complication of DBS. Early detection and timely management with corticosteroids are critical for symptom resolution and successful continuation of DBS therapy. Vigilant postoperative monitoring and further research are essential to improve understanding and management of PLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.